Taiwan Liposome Company Ltd
Biotechnology
Healthcare
TLC
42.08M shares
NASDAQ US
traded
28 Sep 2021
open
7.00
52 week high
7.63
high
7.09
52 week low
4.10
low
7.00
growth
47.68%
previous Close
7.00
P/E ratio
-175
market cap
303M
div yield
0
usd
Jun 2021
qoq
revenue
160M
325.80 %
net incoming
-75.51M
65.40 %
eps
-0.04
50.00 %
eps surprise
80.00 %
net profit margin
-47.14 %
5.33 %
operating incoming
-91.53M
57.66 %
net change in cash
-383.27M
-45.92 %
cash on hand
cost of revenue
top top